A61K 2039/544
To the airways
Official title: {to the airways}
A61K2039/544 (To the airways) appears on 161 US grants and 300 published applications in this corpus.
Search patents in A61K- Granted patents
- 161
- Published applications
- 300
- Assignees
- 192
- Inventors
- 695
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 5 |
| 2003 | 2 | 4 |
| 2004 | 0 | 4 |
| 2005 | 0 | 10 |
| 2006 | 2 | 7 |
| 2007 | 2 | 5 |
| 2008 | 1 | 8 |
| 2009 | 3 | 11 |
| 2010 | 6 | 9 |
| 2011 | 1 | 13 |
| 2012 | 2 | 9 |
| 2013 | 6 | 12 |
| 2014 | 5 | 7 |
| 2015 | 7 | 7 |
| 2016 | 9 | 18 |
| 2017 | 12 | 13 |
| 2018 | 13 | 13 |
| 2019 | 8 | 15 |
| 2020 | 14 | 9 |
| 2021 | 5 | 20 |
| 2022 | 8 | 17 |
| 2023 | 11 | 20 |
| 2024 | 8 | 19 |
| 2025 | 8 | 26 |
| 2026 | 3 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic protein formulations comprising anti-DNABII antibodies and uses thereof2 Jun 2026US 12,643,941 B2Trellis Bioscience, LLC
- Therapeutic efficacy by pulmonary delivery of live attenuated mycobacteria17 Feb 2026US 12,551,512 B2Universidad De Zaragoza
- Methods of permeabilizing the blood brain barrier6 Jan 2026US 12,514,828 B2University of Southern California
- Subcutaneous dosing of anti-CD20/anti-CD3 bispecific antibodies9 Dec 2025US 12,492,261 B2Genentech, Inc.
- Methods of targeted delivery to a host using a carrier9 Sep 2025US 12,409,149 B2Finncure Oy
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Methods of eliciting an immune response against clostridium perfringens and/or necrotic enteritis and compositions for use thereof13 Aug 2026US 2026/0232784 A1University of Saskatchewan
- Method For Prevention or Treatment of Coronavirus Infection13 Aug 2026US 2026/0234222 A1Leyden Laboratories B.V.
- Helper lipids for nucleic acid delivery6 Aug 2026US 2026/0224688 A1Sanofi Pasteur Limited
Most cited
By later US patents
- Dispersible antibody compositions and methods for their preparation and use351US 6,019,968 AInhale Therapeutic Systems · 2000
- Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases34US 9,457,077 B22016
- Antigen-binding molecule capable of binding two or more antigen molecules repeatedly33US 10,472,623 B2Chugai Seiyaku Kabushiki Kaisha · 2019
- Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly33US 9,890,377 B2Chugai Seiyaku Kabushiki Kaisha · 2018
- Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases30US 9,750,802 B22017